Pursuant to Regulation 34(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''SEBI Listing Regulations''), please find ....

Bliss GVS Pharma Ltd has submitted its Annual Report for the financial year 2025-26 and the Notice convening its 41st Annual General Meeting (AGM), scheduled for July 15, 2026. The company also announced Wednesday, July 08, 2026, as the Record Date for determining the entitlement of members to the final dividend for FY26. If approved at the AGM, the dividend payment will be made on or before Friday, August 14, 2026.